Europe Archives | Be Korea-savvy
Jeito Capital Becomes a Key Player in the Financing of Life Sciences in Europe with the Closing of Jeito I at €534 Million ($630 Million)

Jeito Capital Becomes a Key Player in the Financing of Life Sciences in Europe with the Closing of Jeito I at €534 Million ($630 Million)

Paris, Sept. 20 (Korea Bizwire) – Jeito Capital, a rapidly growing, new, independent Private Equity firm dedicated to biotech and biopharma, today announced the final closing of its first fund, Jeito I, at €534 million ($630 million), exceeding its original target of €500 million. Jeito I is the largest European fund dedicated to supporting companies in [...]

Samsung Bioepis Gets Nod for Sale of Ophthalmology Biosimilar Drug in Europe

Samsung Bioepis Gets Nod for Sale of Ophthalmology Biosimilar Drug in Europe

SEOUL, Aug. 23 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Bioepis Co. said Monday it has won approval from European authorities for the sale of its ophthalmology biosimilar, Byooviz. The European Commission granted the marketing authorization on ranibizumab biosimilar, previously known as SB11, which references Swiss pharmaceutical giant Novartis’ blockbuster medication Lucentis. It is [...]

Kia EV6 Draws Strong Preorders in Europe

Kia EV6 Draws Strong Preorders in Europe

SEOUL, May 5 (Korea Bizwire) — Kia Corp., South Korea’s No. 2 automaker, said Wednesday its first all-electric model, the EV6, logged decent presale orders in Europe. According to the automaker, presale orders for the EV have topped 7,000 in Britain, France, Germany and other major countries, with the number set to further rise. Kia [...]